Prostate-Specific Antigen (PSA) Test
• Total PSA (tPSA):
o Measures overall PSA levels in the blood.
o Used as the primary screening test.
• Free PSA (fPSA):
o Measures unbound PSA.
o Lower free PSA percentage suggests a higher cancer risk.
• PSA Density (PSAD):
o Adjusts PSA levels based on prostate volume
o Helps differentiate BPH from cancer.
• PSA Velocity (PSAV):
o Tracks PSA level changes over time.
o Rapid increase may indicate aggressive cancer.
• PSA Doubling Time (PSADT):
o Measures how quickly PSA levels double.
o Faster doubling suggests more aggressive cancer.
• Pro-PSA & Prostate Health Index (PHI):
o Includes p2PSA, total PSA, & free PSA
o To improve cancer detection & reduce unnecessary biopsies.
• 4Kscore Test:
o Evaluates four PSA-related proteins along with clinical factors.
o To estimate the risk of high-grade cancer.
• PCA3 Test:
o Urine-based genetic test detecting PCA3 mRNA.
o Highly specific to prostate cancer.
• IsoPSA Test:
o Analyzes PSA structural changes to distinguish benign conditions from cancer.
SIRS vs Sepsis
Systemic Inflammatory Response Syndrome (SIRS)
- Non-specific (infections vs non-infectious)
- ≥2 of the following:
- Temp >38°C or <36°C
- HR >90 bpm
- RR >20 or PaCO₂ <32 mmHg
- WBC >12,000/mm³, <4,000/mm³, or >10% bands
Sepsis
- Organ dysfunction due to dysregulated host response to infection.
- SOFA score increases by ≥2.
- qSOFA (≥2 indicates high risk):
- Altered mental status (GCS <15)
- RR ≥22/min
- SBP ≤100 mmHg
Severe Sepsis (Obsolete Term in Sepsis-3, 2016)
• Sepsis + tissue hypoperfusion/organ dysfunction.
Septic Shock
• Sepsis + circulatory failure
- Hypotension requiring vasopressors (MAP <65 mmHg).
- Lactate >2 mmol/L
Management (Surviving Sepsis Campaign Guidelines)
- Early recognition & treatment (within 1 hour)
- IV fluids (30 mL/kg crystalloid in 1st 3 hours)
- Broad-spectrum antibiotics ASAP
- Vasopressors (norepinephrine) if MAP <65 mmHg
- Source control (drain abscesses, remove infected devices)
- Supportive care (oxygenation, ventilation, glycemic control, DVT/stress ulcer prophylaxis)